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abstract
Free radical damage has been associated with a growing number of diseases and conditions, such as autoimmune 
diseases, neurodegenerative disorders and multiple types of cancer. Some dehydroamino acids and correspond-
ing peptides can function as radical scavengers. In this study the in vitro effects on rat liver lipid peroxidation lev-
els of fourteen N-substituted dehydroamino acid derivatives and α-tocopherol were investigated. α-Tocopherol 
is a powerful antioxidant that is beneficial in the treatment of many free radical related diseases. The results 
indicated that all the compounds showed very good inhibitory effect on the lipid peroxidation compound with 
α-tocopherol at 1 mM concentrations and the inhibition rate was in the range of 70–79 % with the exception of 
compound 5. At 0.1 mM concentrations compounds 1, 2 and 9 were found more active than α-tocopherol. The 
results confirmed that molecules such as dehydroamino acids which have reactive double bonds can act as a 
guard in vitro against oxidants.
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Introduction
The implication of oxidative stress in the pathogenesis of 
many chronic diseases such as cancer, atherosclerosis, and 
several neurodegenerative disorders has led to the com-
monly accepted point of view that antioxidants could be ben-
eficial and prevent these diseases [1]. Oxidative stress may 
occur either due to the over production of reactive oxygen 
species (ROS) or to decrease of cellular antioxidant levels. 
Free radicals and ROS generated in tissues and sub-cellular 
compartments are efficiently scavenged by the antioxidant 
defense system, which constitutes antioxidant enzymes [2], 
such as superoxide dismutase, catalase, glutathione peroxi-
dase, and glutathione reductase. Oxidative stress is defined 
as the imbalance between oxidants and anti-oxidants in 
favor of the oxidants potentially leading to damage. When 
there is an excessive production of ROS or impaired antioxi-
dant defense mechanisms, oxidative stress occurs. Hence, 
any excess ROS must be continuously inactivated in order to 
maintain normal cell function either by antioxidant enzymes 
or using synthetic antioxidant supplement.
Dehydroamino acids represent a significant class of 
compound as they are key intermediates in amino acid 
and peptide synthesis and are found in variety of naturally 
occurring antibiotics [3–5]. They also play an important role 
at the active site of some enzymes and show free radical 
scavenging activity [6–9]. Dehydroalanine derivatives are 
useful also for protecting the skin, the mucous membranes 
and the hair against oxidative stress [10]. Wagner et al [11] 
showed that dehydroalanyl residue can capture the 5’-de-
oxyadenosyl radical generated from S-adenosylmethionine 
by pyruvate formate-lyase-activating enzyme. N-(acylaryl)-
dehydroalanine derivatives have shown inhibitory activity 
towards oxygen radicals [12,13]. Captodative substituted 
olefins are radical scavengers which react with free radicals 
to form stabilized radical adducts. One of those compounds, 
N-(paramethoxyphenylacetyl) dehydroalanine, may react 
and scavenge both superoxide anion (O
2
-) and alkoxyl radi-
cals (RO.), and in this way prevent the appearance of their 
mediated biological effects. The inhibitory effect of this 
compound [14] implies that O
2
- is scavenged more efficiently 
than RO.. N-Acyl dehydroalanines have shown free radical 
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scavenging  activity. They react with and scavenge mainly 
oxygen-derived free radicals such as the O
2
- and the hydroxyl 
radical (HO.) and they protect from radiation toxicity and 
inhibit radiation carcinogenesis in mice [14].
Molecules, which contain Michael acceptor functionali-
ties such as olefins or acetylenes, protect against the toxicity 
of oxidants and electrophiles indirectly, i.e., by inducing 
phase 2 cytoprotective enzymes. This may be beneficial 
to antioxidant functions [15–17]. The presence of Michael 
acceptor groups at critical positions was found essential not 
only for anti-inflammatory activity, but also for inhibition 
of proliferation, promotion of differentiation, and induction 
of apoptosis in various cell lines in terpenoid (isoprene) 
type compounds [18–21]. The reactivity of N-substituted 
dehydroalanines with hydroxyl radical is evident from 
their inhibition of hydroxyl radical adduct formation. ESR 
spin trapping studies of the species formed by reaction of 
the dehydroalanine derivatives with the hydroxyl radi-
cal was reported by Sipe et al [22]. Earlier we have shown 
that N-acetyl dehydroalanine derivatives had strong effect 
on the Lipid Peroxidation [23]. Therefore, it was of interest 
to investigate antioxidant ability of N-substituted dehy-
droamino acid derivatives. This study has surveyed the in 
vitro effects on rat liver lipid peroxidation levels of four-
teen N-substituted dehydroalanine derivatives (Scheme 1 
and 2). These compounds were previously synthesized by 
Ferreira et al [24–26] using -elimination and Michael addi-
tion reactions.
It has been claimed that -tocopherol is the most impor-
tant lipid-soluble antioxidant, and it protects cell membranes 
from oxidation by reacting with lipid radicals produced in the 
lipid peroxidation chain reaction [27]. This removes the free 
radical intermediates and prevents the oxidation reaction 
from continuing. These findings have prompted us to inves- tigate comparative effect of N-substituted dehydroamino 
acids and -tocopherol on rat liver lipid peroxidation.
Materials and methods
Chemicals
-Tocopherol, thiobarbituric acid (TBA), malondialdehyde 






, butanol were purchased 
from Sigma Chemical Co. (St Louis, MO, USA).
Synthesis of N-substituted dehydroamino acids
These compounds were previously synthesized and char-
acterized by Ferreira et al [24–26] using -elimination and 
Michael addition reactions (Schemes 1 & 2).
Assay of lipid peroxidation
The effect of crude extract on rat liver homogenate induced 
with FeCl
2
-ascorbic acid and lipid peroxidation (LP) was 
determined by the method of modified Mihara et al [28]. 
Wistar rats (200–225 g) were fed with standard laboratory rat 
chow and tap water ad libitum. The animals were starved for 
24 h prior to sacrifice and then killed by decapitation under 
anesthesia. The study was carried out in accordance with the 




































Scheme 2. The methyl esters of N-substituted dehydrodipeptide (8, 9), 
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were removed immediately and washed in ice-cold distilled 
water, and homogenized immediately with Teflon homog-
enizer in ice. LP was measured spectrophotometrically 
by estimation of thiobarbituric acid reactant substances 
(TBARS). Amounts of TBARS were expressed in terms of 
mol malondialdehyde (MDA)/g tissue. A typical optimized 
assay mixture contained 0.5 mL of liver homogenate, 0.1 mL 
0.1 M (buffer capacity t= 0.010) of Tris-HCl buffer (pH 7.2), 
0.05 mL of 0.1 mM ascorbic acid, 0.05 mL of 4mM FeCl
2
 and 
0.05 mL of various concentration of N-substituted dehy-
droalanine derivative, or -tocopherol. This mixture was 





and 1 mL of 0.6% TBA were added and shaken vigorously. 
The mixture was boiled for 30 min. After cooling, butanol 
was added and the mixture was shaken vigorously. The 
butanol phase was separated by centrifugation at 3000 rpm 
for 10 min. The absorbance of the supernatant was read at 
532 nm against a blank, which contained all reagents except 
liver homogenate. -Tocopherol was used as positive con-
trol. Lipid peroxidation inhibitory activity (%) is expressed 
as follows:
Lipid peroxidation inhibitory activity (%):  











 is the absorbance of the control, A
sample
 is the 
absorbance of the sample and A
blank
 is the absorbance of the 
blank, to which the sample and the free radical generating 
system (Fe+2/ascorbate) were not added.
Statistical analysis
All data are the average of duplicate analyses. The data 
were recorded as mean ± standard deviation and analyzed 
by SPSS (version 11.0 for Windows 98 SPSS Inc.). One-way 
analysis of variance was performed by ANOVA procedures. 
Significant differences between means were determined 
by Duncan’s multiple range tests. Values of p <0.05 were 
regarded as significant.
Results
The results indicated that all the compounds studied have a 
noticeable effect on the inhibition of lipid peroxidation (LP) 
at the 1mM concentration. They are summarized in Table 1. 
At a concentration of 1mM all the tested compounds inhib-
ited LP between 70–79 %, with the exception of compound 5 
(methyl ester of N-tert-butoxycarbonyldehydroalanine) that 
showed 40 % inhibition at the same concentration. At a con-
centration of 0.1mM while compounds 1, 2 and 9 showed 
higher activity than -tocopherol, compounds 3, 7, 8, 13 
and 14 showed moderate inhibition activity between 13–20 
% and finally compounds 6, 10 and 11 showed low inhibi-
tion activity between 4–9%. It is noticeable that the activities 
of the tested compounds at 1mM concentration are much 
higher than the standard -tocopherol.
Interesting results were obtained from compounds 4, 5 and 
12 that showed pro-oxidant activity at concentration of 0.1 
mM. Pro-oxidants are chemicals that induce oxidative stress, 
either through creating reactive oxygen species or inhibiting 
antioxidant systems. This result is not surprising because 
some antioxidant compounds may show pro-oxidant activity 
such as -tocopherol which is a classical lipid-soluble anti-
oxidant and well known scavenger of free radicals [29].
On the other hand all the compounds were tested using 
DPPH radical scavenging activity and superoxide (O
2
.-) radi-
cal scavenging activity assays. No significant results were 
obtained with these tests. All the compounds had no effect 
on DPPH radical scavenging activity that was tested by 
measuring the dehydroalanine derivatives ability to bleach 
the stable radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) 
according to the modified method of Blois [30]. The superox-
ide radical scavenging activity was tested by measuring the 
capacity of dehydroalanines to scavenge superoxide anion 
which was determined spectrophotometrically on the basis 
of inhibition of cytochrome c reduction according to the 
modified method of McCord et al [31]. Because compounds 
were inactive for scavenging DPPH and O
2
.- radical the data 
is not shown.
Table 1. Anti-Lipid Peroxidation Effects of synthesized compoundsa.
Compoundsb
Concentrations 
(mM) mol MDA/g tissue % Inhibition
1 0.1 0.91±0.01* 42±1.5
1 0.34±0.01* 78±0.3
2 0.1 0.83±0.04* 47±1.5
1 0.36±0.01* 77±0.7
3 0.1 1.38±0.13* 13±1.9
1 0.33±0.01* 79±1.4
4 0.1 3.76±1.17* PE
1 0.40±0.01* 75±2.2
5 0.1 2.48±0.43* PE
1 0.95±0.02* 40±0.8
6 0.1 1.51±0.12 4±1.6
1 0.40±0.01* 75±2.2
7 0.1 1.28±0.1 19±1.8
1 0.36±0.01* 77±0.7
8 0.1 1.16±0.03 27±0.8
1 0.40±0.01* 75±1.2
9 0.1 0.95±0.06 40±1.9
1 0.40±0.01* 75±1.4
10 0.1 1.46±0.08 8±1.2
1 0.41±0.01* 74±2.4
11 0.1 1.44±0.14 9±2.2
1 0.47±0.01* 70±1.4
12 0.1 1.84±0.13 PE
1 0.35±0.01* 78±1.7
13 0.1 1.21±0.04 23±0.8
1 0.40±0.01* 75±2.4
14 0.1 1.26±0.07 20±1.1
1 0.34±0.01* 78±0.7
Control - 1.58±0.13 -
-tocopherol 0.1 1.06±0.03* 33±1.4
1 0.75±0.02* 53±2.0
aThe values represent the average of 2–4 determinations ± standard 
deviations.
bCompounds were diluted with DMSO (solvent expressed no antioxidant 
activity).
*Significance of differences vs. control at p<0.05. PE: Prooxidant effect
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Discussion
Dehydroamino acids are essential intermediates in the 
design of peptides and some antibiotics [32]. Olefins such as 
dehydroalanines have been shown to inactivate free radicals 
by forming stabilized free radical adducts. It has been shown 
that N-substituted dehydroalanines react with and scavenge 
oxygen radicals. Also they inhibit lipid peroxidation with a 
different degree of efficacy [7].
Lipid peroxidation can be characterized as the oxida-
tive deterioration of lipids containing any number of 
carbon-carbon double bonds. The process whereby free 
radicals take electrons from the lipids of cell membranes, 
resulting in cell damage and increased production of free 
radicals. In a peroxide-free lipid system, the peroxidation 
sequence starts by the attack of a ROS to a hydrogen atom 
that has a high mobility. This attack generates simply free 
radicals from polyunsaturated fatty acids. .OH is the most 
efficient ROS to do that attack [33,34]. This peroxidation 
process is inhibited by compounds such as tocopherols, 
mannitol and formate. The presence of a double bond in 
the fatty acid weakens the C-H bonds on the carbon atom 
adjacent to the double bond and so makes H removal 
easier. The carbon radical tends to be stabilized by a 
molecular rearrangement to form a conjugated diene. 
Although we have good information there is still specu-
lation as to the role of the dehydro units in biologically 
active compounds. Certainly, they have an influence as 
a conformational constraint due to their sp2 hybridized 
carbon structure, however, they could well have the abil-
ity to add on nucleophiles via Michael type conjugative 
addition, as recently proven in a set of model experiments 
[35]. In dehydroalanine type compounds, free radicals 
are most probably attacked to the carbon-carbon double 
bond and the resulting radical adduct is formed easily 
by the effect of the groups next to the dehydro unit. N,N-
diprotected dehydroalanine derivatives were found excel-
lent substrates of Michael addition reactions by Ferreira 
et al [25,26,36,37] but the mono-protected derivatives 
were found relatively poorer Michael acceptors than the 
other tested compounds [25,26]. There was no significant 
correlation found between the antioxidant activity results 
and the Michael acceptor properties of the compounds. 
This could be due to more complex chemical structure of 
the tested compounds than the compounds we worked 
earlier in our studies [23].
All the compounds were effective only in LP experi-
ment allowing the conclusion that these dehydroalanine 
derivatives are able to scavenge OH. radical rather than 
DPPH or superoxide radicals. This result is similar to 
our earlier findings [23] in which some N-acyl dehy-
droalanine derivatives showed a strong inhibitory effect 
on lipid peroxidation at 10-3M and 10-4M concentrations 
(76–90%), while they had very little or no effect on DPPH 
radical.
The results established that molecules such as dehy-
droamino acids which are reactive Michael acceptors can be 
active in in vitro against the oxidants.
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